Related Experiment Video
Updated: Apr 27, 2026

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
An update on the use of melatonin as a stroke therapeutic
G S Gonzales-Portillo1, D Lozano, D Aguirre
1Department of Neurosurgery and Brain Repair, Center of Excellence for Aging and Brain Repair, University of South Florida College of Medicine, Tampa, FL, USA - ntajiri@health.edu.
Abstract:
Delivery of melatonin and targeting melatonin receptors pose as neuroprotective strategies for stroke therapy. The potential of melatonin-based therapeutics for clinical application in stroke patients requires translational research to guide the conduct of clinical trials. We review recent preclinical and clinical data that support the use of melatonin for stroke.
More Related Videos
Related Concept Videos
Management of Insomnia
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Hemorrhagic Stroke ll: Pathophysiology

